180 related articles for article (PubMed ID: 21739269)
21. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
22. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
23. Presumed primary papillary sebaceous carcinoma of the palpebral conjunctiva.
Jakobiec FA; Stagner AM; Nowak MA; Rubin PA
JAMA Ophthalmol; 2015 May; 133(5):612-4. PubMed ID: 25654538
[No Abstract] [Full Text] [Related]
24. Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
Cheng AY; Lan J; Lee CH
J Dermatol; 2022 Jun; 49(6):600-606. PubMed ID: 35318716
[TBL] [Abstract][Full Text] [Related]
25. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract][Full Text] [Related]
27. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.
Li CC; Xu B; Hirokawa M; Qian Z; Yoshimoto K; Horiguchi H; Tashiro T; Sano T
Virchows Arch; 2002 Feb; 440(2):145-54. PubMed ID: 11964044
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
29. Role of fine needle aspiration cytology in diagnosis of eyelid sebaceous carcinoma.
Maheshwari R; Maheshwari S; Shekde S
Indian J Ophthalmol; 2007; 55(3):217-9. PubMed ID: 17456941
[TBL] [Abstract][Full Text] [Related]
30. Sebaceous carcinoma of the lung: histologic and immunohistochemical characterization of an unusual pulmonary neoplasm: report of a case and review of the literature.
Borczuk AC; Sha KK; Hisler SE; Mann JM; Hajdu SI
Am J Surg Pathol; 2002 Jun; 26(6):795-8. PubMed ID: 12023586
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract][Full Text] [Related]
32. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
33. Management of eyelid sebaceous carcinomas.
Dogru M; Matsuo H; Inoue M; Okubo K; Yamamoto M
Ophthalmologica; 1997; 211(1):40-3. PubMed ID: 8958530
[TBL] [Abstract][Full Text] [Related]
34. [Sebaceous carcinoma of the eyelid--two case reports].
Zieliński T; Antoszewski B
Klin Oczna; 2014; 116(2):127-9. PubMed ID: 25345292
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
[TBL] [Abstract][Full Text] [Related]
36. Sebaceous carcinoma of the caruncle.
Shields JA; Shields CL; Marr BP; Eagle RC
Cornea; 2006 Aug; 25(7):858-9. PubMed ID: 17068467
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance.
Jayaraj P; Sen S
Indian J Ophthalmol; 2019 Dec; 67(12):1983-1987. PubMed ID: 31755433
[TBL] [Abstract][Full Text] [Related]
40. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
